Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study) (Q34777452)

4 August 2017

Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study) (English)

1 reference

4 August 2017

0 references

cervix uterine cancer

1 reference

Elisa J Young

1

0 references

Yasmin Jayasinghe

object named as

Yasmin Jayasinghe

8

0 references

Sepehr N Tabrizi

2

object named as

Sepehr N Tabrizi

1 reference

4 August 2017

Suzanne Marie Garland

12

object named as

Suzanne M Garland

1 reference

4 August 2017

3

Julia Ml Brotherton

1 reference

4 August 2017

10

Dorota M Gertig

1 reference

4 August 2017

John D Wark

4

1 reference

4 August 2017

Jan Pyman

5

1 reference

4 August 2017

Marion Saville

6

1 reference

4 August 2017

C David Wrede

7

1 reference

4 August 2017

Jeffrey Tan

9

1 reference

4 August 2017

Marian Pitts

11

1 reference

4 August 2017

language of work or name

English

0 references

publication date

19 June 2013

1 reference

4 August 2017

1 reference

4 August 2017

13

1 reference

4 August 2017

296

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-296

4 August 2017

0 references

cites work

A review of clinical trials of human papillomavirus prophylactic vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Web-based recruiting for health research using a social networking site: an exploratory study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Efficacy and other milestones for human papillomavirus vaccine introduction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Treatment for cervical intraepithelial neoplasia and risk of preterm delivery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

The psychological impact of abnormal cytology and colposcopy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Improved amplification of genital human papillomaviruses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Human papillomavirus genotyping using a modified linear array detection protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-296

Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751671

Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus

26 October 2018

1 reference

12 December 2020

How much cervical cancer in Australia is vaccine preventable? A meta-analysis

1 reference

12 December 2020

Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system

1 reference

12 December 2020

Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy

1 reference

12 December 2020

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-13-296

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference